GHUCCTS

News

Share This
  • Aug 06, 2020

GHUCCTS team members discuss clinical trial participation among African Americans with radio and news outlets


GHUCCTS Community Engagement (CE) team members Dr. Carla Williams and Florencia Gonzalez speak with the Center for Health Journalism at USC and Howard University Radio WHUR 96.3 about the importance of diversity in clinical trials.

Candace Y.A. Montague with the University of Southern California's Center for Health Journalism interviewed both Dr. Williams and Ms. Gonzalez for the article Recruiting Black volunteers for COVID-19 vaccine trials means overcoming mistrust. In the piece Dr. Williams emphasizes patient safety for both researchers and participants, noting that "it’s important that people know that there are strong safeguards in place to protect their safety and confidentiality. This includes a careful process of reviewing a research project before giving approval to start enrolling people in a study.” Ms. Gonzalez adds that thoughtful and personalized materials, especially for participants with limited English proficiency, can also help build trust while making sure participants understand their rights. 

Dr. Williams goes into greater detail about the importance of building trust among the Africian American community in her interview on Howard University Radio WHUR 96.3. In a joint interview with Dr. Lisa Fitzpatrick, Infectious Disease Physician and Founder of Grapvevine Health, Dr. Williams talks about the current and historical barriers that exist that may discourage African Americans from participating in clinical trials, and how we can rebuild that trust and ensure patient protections moving forward. An archive of the interview can be found on the WHUR website.

Related News

Request for Applications: 2022 KL2 Scholars Program

Mar 10, 2022

The GHUCCTS KL2 Scholars Program is now accepting applications for our 2022 funding cycle. Applicants must have a full-time faculty or equivalent appointment at a GHUCCTS institution (Georgetown University, Howard University, or MedStar Health) at the time of award activation.

Request for Applications: 2022-2023 TL1 Translational Biomedical Science Program

Mar 07, 2022

The GHUCCTS TL1 Translational Biomedical Science (TBS) Program is now accepting applications for our 2022-2023 funding cycle. Applicants should be predoctoral students who have completed their qualifying exams in PhD programs at Howard or Georgetown Universities or Postdoctoral fellows who have a primary appointment at Georgetown or Howard Universities, a MedStar Institution, or the Washington DC VAMC.

Close